Search
Menu
Home
HTB
2019
July
17
17 July 2019
Contents
Editorial
HTB 17 July 2019 online: IAS 2019, HIV pipeline, gene-cure mice…
Special reports
HIV pipeline report 2019
Conference reports
Upcoming 10th IAS Conference on HIV Science (IAS 2019)
IAS 2019: late breaker highlights to look for
Antiretrovirals
Dolutegravir/lamivudine approved as dual HIV combination in EU
Guidelines
IAS–USA update of drug resistance mutations (2019)
Cure-related research
HIV risk to partners of people in studies with a treatment interruption
Gene editing to eliminate HIV from mice: misleading and wrongly reported in media coverage
Other news
UNAIDS call on 48 countries and territories to remove all HIV-related travel restrictions
PDFs
17 July 2019 vol 20 no 8
HTB RSS
Early access
Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news
4 May 2025
The RIO study: Q&A about controlling HIV with bNAbs
21 April 2025
Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years
20 April 2025
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
13 April 2025
All early access reports
Current issues
May 2025
April 2025
March 2025
Back issues
Special report
Reduced dosing: a possible crisis response to ART stockouts and closed clinics
5 May 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate